HMG-CoA Lyase Deficiency: A Retrospective Study of 62 Saudi Patients
- PMID: 35646072
- PMCID: PMC9136170
- DOI: 10.3389/fgene.2022.880464
HMG-CoA Lyase Deficiency: A Retrospective Study of 62 Saudi Patients
Abstract
3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (HMG-CoA lyase) is a rare inborn error of leucine degradation and ketone body synthesis, caused by homozygous or compound heterozygous disease-causing variants in HMGCL. To understand the natural history of this disease, we reviewed the biochemical, clinical, and molecular data of 62 patients from 54 different families with confirmed HMG-CoA lyase deficiency (HMGCLD) diagnosis from Saudi Arabia. The majority of the affected individuals were symptomatic. At initial diagnosis, 38 patients (61.29%) presented with hypoglycemia and 49 patients (79.03%) developed metabolic acidosis. In 27 patients (43.54%), the disorder manifested in the neonatal period, mostly within the first days of life, while 35 (56.45%) patients were diagnosed within the first year of life or beyond. All the patients were alive and developed long-term neurological complications during data collection, which may significantly influence their quality of life. Common neurological findings include seizures 17/62 (27.41%), hypotonic 3/62 (4.83%), speech delay 7/62 (11.29%), hyperactivity 4/62 (4.83%), developmental delay 6/62 (9.677%), learning disability 15/62 (24.14%), and ataxic gate 1/62 (1.612%). An MRI of the brain exhibited nonspecific periventricular and deep white matter hyperintense signal changes in 16 patients (25.80%) and cerebral atrophy was found in one (1/62; 1.612%) patient. We identified a founder variant [c.122G>A; p.(Arg41Gln)] in 48 affected individuals (77.41%) in the HMGCL gene. This is the largest cohort of HMGCLD patients reported from Saudi Arabia, signifying this disorder as a likely life-threatening disease, with a high prevalence in the region. Our findings suggest that diagnosis at an early stage with careful dietary management may avoid metabolic crises.
Keywords: HMG-CoA lyase; HMGCL; Ketogenesis; Saudi Arabia; acidosis; hypoglycemia; ketone body synthesis.
Copyright © 2022 Alfadhel, Abadel, Almaghthawi, Umair, Rahbeeni, Faqeih, Almannai, Alasmari, Saleh, Eyaid, Alfares and Al Mutairi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients.Mol Genet Metab. 2017 Jul;121(3):206-215. doi: 10.1016/j.ymgme.2017.05.014. Epub 2017 May 22. Mol Genet Metab. 2017. PMID: 28583327
-
3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: case report of a child with rare HMGCL gene variants.J Pediatr Endocrinol Metab. 2025 Jun 13. doi: 10.1515/jpem-2025-0156. Online ahead of print. J Pediatr Endocrinol Metab. 2025. PMID: 40513556
-
Inborn Errors of Ketogenesis: Novel Variants, Clinical Presentation, and Follow-Up in a Series of Four Patients.J Pediatr Genet. 2022 Jul 12;13(1):22-28. doi: 10.1055/s-0042-1749362. eCollection 2024 Mar. J Pediatr Genet. 2022. PMID: 38567177 Free PMC article.
-
MRI and MRS in HMG-CoA lyase deficiency.Pediatr Neurol. 1999 May;20(5):375-80. doi: 10.1016/s0887-8994(99)00013-2. Pediatr Neurol. 1999. PMID: 10371384 Review.
-
Molecular genetics of HMG-CoA lyase deficiency.Mol Genet Metab. 2007 Nov;92(3):198-209. doi: 10.1016/j.ymgme.2007.06.020. Epub 2007 Aug 9. Mol Genet Metab. 2007. PMID: 17692550 Review.
Cited by
-
Mutated neuron navigator 3 as a candidate gene for a rare neurodevelopmental disorder.Mol Genet Genomic Med. 2024 Jul;12(7):e2473. doi: 10.1002/mgg3.2473. Mol Genet Genomic Med. 2024. PMID: 39038237 Free PMC article.
-
A Novel Loss of Function Variant in HCN1 Gene Underlies Early Infantile Epileptic Encephalopathy 24 [EIEE24].Mol Syndromol. 2025 Apr;16(2):152-164. doi: 10.1159/000541117. Epub 2024 Oct 9. Mol Syndromol. 2025. PMID: 40176840
-
Outcomes of cases with elevated 3-hydroxyisovaleryl carnitine report from the newborn screening program.Mol Genet Metab Rep. 2024 Oct 13;41:101153. doi: 10.1016/j.ymgmr.2024.101153. eCollection 2024 Dec. Mol Genet Metab Rep. 2024. PMID: 39484073 Free PMC article.
-
Consanguinity and Occurrence of Monogenic Diseases in a Single Tertiary Centre in Riyadh, Saudi Arabia: A 2 Years Cross-Sectional Study.Appl Clin Genet. 2024 Oct 3;17:151-158. doi: 10.2147/TACG.S476350. eCollection 2024. Appl Clin Genet. 2024. PMID: 39377010 Free PMC article.
-
Non-invasive prenatal testing for autosomal recessive disorders: A new promising approach.Front Genet. 2022 Nov 3;13:1047474. doi: 10.3389/fgene.2022.1047474. eCollection 2022. Front Genet. 2022. PMID: 36406136 Free PMC article.
References
-
- Alfadhel M., Benmeakel M., Hossain M. A., Al Mutairi F., Al Othaim A., Alfares A. A., et al. (2016). Thirteen Year Retrospective Review of the Spectrum of Inborn Errors of Metabolism Presenting in a Tertiary center in Saudi Arabia. Orphanet J. Rare Dis. 11 (1), 126. 10.1186/s13023-016-0510-3 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources